Speaker Profile

Lead, Healthcare Market Access, Illumina

Biography
Genomics and healthcare leader building clinical and population solutions supporting the healthcare ecosystem. Numerous precision medicine leadership roles in leading health systems, molecular diagnostics, therapeutic development, and genomics/ life science.

Talk
PGx – This Old Dog’s New Tricks
Despite guidelines, technology cost decreases, select EMR integration and payer acceptance – PGx is far from routine care. As the evidence has matured, the market has also evolved with opportunities at the intersection of Value-Based Care and Precision Medicine.This conversation will discuss the field’s progress and opportunity dynamics across stakeholders.


 Session Abstract – PMWC 2023 Silicon Valley

Track 1 - January 27 9.00 A.M.-4.30 P.M.


Track Co-Chair:
Mary Relling, St. Jude

Pharmacists have long recognized that using unique patient characteristics to guide pharmacotherapy decision-making can improve drug response and mitigate drug-associated risks. Age, weight, and dietary habits were among the first patient-specific characteristics used to individualize pharmacotherapy. As technologies advanced, analytic tools that measure surrogate markers of liver and renal function, together with drug concentrations in biological fluids, were adopted to optimize therapeutic regimens. Cutting-edge genomic technologies are now being integrated into patient care for the selection of targeted therapies and identification of those at increased risk of poor pharmacotherapy outcomes. We’re excited to bring together experts who are advancing pharmacogenomics at scale through cutting edge clinical implementation, research, and education.

  • PMWC 2023 PGx Award Ceremony:
    Pioneer Honoree: Dan Roden, Vanderbilt University Medical Center
    Luminary Honoree: Kelly E. Caudle, St. Jude
  • Fireside Chat
    PMWC 2023 Pioneer Honoree Dan Roden, Vanderbilt University Medical Center with Mary Relling, St. Jude
  • PMWC 2023 Honoree Keynote
    - Kelly E. Caudle, St. Jude
  • Laboratory Testing and Reports
    Chair: Kristy Crooks, University of Colorado
    - Ann M. Moyer, Mayo Clinic
    - Stuart Scott, Stanford University
  • From Economics to Reimbursement (PANEL)
    Chair: Sara Rogers, American Society of Pharmacovigilance
    - Stirling Bryan, The University of British Columbia
    - Ray Stultz, Optum
    - Gabriel Bien-Willner, Palmetto GBA
  • Policy Efforts to Address Barriers to PGx Adoption
    Chair: Kristine Ashcraft, Invitae
    - Pam Traxel, ACS CAN
  • PGx Practice Liability
    - Dan Hertz, University of Michigan
    - Anthony Morreale, VA, San Diego
    - Karen Merritt, Patient Advocate
  • Diversity, Equity, and Inclusion in Pharmacogenomics Implementation
    - Carlos Bustamante, Galatea Bio
    - Kathy Giacomini, UCSF
  • TBA (FIRESIDE CHAT)
    Chair: Damon Hostin, Illumina
    - Howard McLeod, Intermountain Health